Assignee
MURAL ONCOLOGY INC
US·3 granted patents·4 pending applications·1 citations·filing 2022–2024
Top patents by PatentIndex Score
7 records- 0185US11945870B2Immunomodulatory IL-2 agents in combination with immune checkpoint inhibitorsMURAL ONCOLOGY INC·Filed 2022·Granted Apr 2, 2024·1 cites·19 claims
- 0278US2025000938A1Compositions and Methods for Subcutaneous Administration of Cancer ImmunotherapyMURAL ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 0374US2024352125A1Immunomodulatory Il-2 Agents in Combination With Immune Checkpoint InhibitorsMURAL ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 0473US11980652B2Compositions and methods for subcutaneous administration of cancer immunotherapyMURAL ONCOLOGY INC·Filed 2022·Granted May 14, 2024·0 cites·58 claims
- 0553US2025032582A1Compositions and methods for cancer immunotherapyMURAL ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 0653US2024182536A1Interleukin 18 variantsMURAL ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 0742US12338293B2UPAR antibodies and fusion proteins with the sameMURAL ONCOLOGY INC·Filed 2022·Granted Jun 24, 2025·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when MURAL ONCOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →